PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 93 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $331,932 | -39.6% | 19,900 | 0.0% | 0.11% | -32.9% |
| Q2 2023 | $549,240 | -96.6% | 19,900 | +15446.9% | 0.17% | -1.2% |
| Q2 2022 | $16,185,000 | +137.6% | 128 | -99.9% | 0.17% | -90.6% |
| Q2 2021 | $6,813,000 | +73.1% | 152,000 | 0.0% | 1.80% | +72.8% |
| Q1 2021 | $3,937,000 | +28.5% | 152,000 | 0.0% | 1.04% | +24.4% |
| Q4 2020 | $3,064,000 | +3.2% | 152,000 | 0.0% | 0.84% | -12.6% |
| Q3 2020 | $2,969,000 | – | 152,000 | – | 0.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $20,647,000 | 6.08% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $19,057,000 | 2.28% |
| Kynam Capital Management, LP | 519,212 | $4,377,000 | 0.92% |
| RTW INVESTMENTS, LP | 4,176,837 | $35,211,000 | 0.81% |
| Tri Locum Partners LP | 199,500 | $1,682,000 | 0.46% |
| Birchview Capital, LP | 38,000 | $320,000 | 0.22% |
| Gratus Capital, LLC | 206,113 | $1,738,000 | 0.18% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,651,887 | $30,785,000 | 0.17% |
| PDT Partners, LLC | 126,038 | $1,063,000 | 0.16% |
| FOX RUN MANAGEMENT, L.L.C. | 40,683 | $343,000 | 0.13% |